• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用机器学习预测骨质疏松症治疗后的骨密度反应,以辅助个性化治疗。

Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy.

机构信息

Department of Orthopaedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

Biomedical Informatics Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

出版信息

Sci Rep. 2021 Jul 5;11(1):13811. doi: 10.1038/s41598-021-93152-5.

DOI:10.1038/s41598-021-93152-5
PMID:34226589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8257695/
Abstract

Osteoporosis is a global health problem for ageing populations. The goals of osteoporosis treatment are to improve bone mineral density (BMD) and prevent fractures. One major obstacle that remains a great challenge to achieve the goals is how to select the best treatment regimen for individual patients. We developed a computational model from 8981 clinical variables, including demographic data, diagnoses, laboratory results, medications, and initial BMD results, taken from 10-year period of electronic medical records to predict BMD response after treatment. We trained 7 machine learning models with 13,562 osteoporosis treatment instances [comprising 5080 (37.46%) inadequate treatment responses and 8482 (62.54%) adequate responses] and selected the best model (Random Forests with area under the receiver operating curve of 0.70, accuracy of 0.69, precision of 0.70, and recall of 0.89) to individually predict treatment responses of 11 therapeutic regimens, then selected the best predicted regimen to compare with the actual regimen. The results showed that the average treatment response of the recommended regimens was 9.54% higher than the actual regimens. In summary, our novel approach using a machine learning-based decision support system is capable of predicting BMD response after osteoporosis treatment and personalising the most appropriate treatment regimen for an individual patient.

摘要

骨质疏松症是全球老龄化人口面临的一个健康问题。骨质疏松症治疗的目标是提高骨密度(BMD)并预防骨折。实现这些目标的一个主要障碍是如何为个体患者选择最佳的治疗方案。我们从 8981 项临床变量中开发了一个计算模型,这些变量包括人口统计学数据、诊断、实验室结果、药物和初始 BMD 结果,这些数据来自 10 年的电子病历,用于预测治疗后的 BMD 反应。我们使用 13562 个骨质疏松症治疗实例(包括 5080 个(37.46%)治疗反应不足和 8482 个(62.54%)治疗反应充分)训练了 7 个机器学习模型,并选择了最佳模型(随机森林,ROC 曲线下面积为 0.70,准确性为 0.69,精确性为 0.70,召回率为 0.89)来单独预测 11 种治疗方案的治疗反应,然后选择最佳预测方案与实际方案进行比较。结果表明,推荐方案的平均治疗反应比实际方案高 9.54%。总之,我们使用基于机器学习的决策支持系统的新方法能够预测骨质疏松症治疗后的 BMD 反应,并为个体患者个性化最适合的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/2ec1b61275dc/41598_2021_93152_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/a886fbf406b9/41598_2021_93152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/c7ac76eb3d76/41598_2021_93152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/54335bc72040/41598_2021_93152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/884f64754b98/41598_2021_93152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/32235ca23f9f/41598_2021_93152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/ff4a1003c340/41598_2021_93152_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/2ec1b61275dc/41598_2021_93152_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/a886fbf406b9/41598_2021_93152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/c7ac76eb3d76/41598_2021_93152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/54335bc72040/41598_2021_93152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/884f64754b98/41598_2021_93152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/32235ca23f9f/41598_2021_93152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/ff4a1003c340/41598_2021_93152_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b104/8257695/2ec1b61275dc/41598_2021_93152_Fig7_HTML.jpg

相似文献

1
Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy.使用机器学习预测骨质疏松症治疗后的骨密度反应,以辅助个性化治疗。
Sci Rep. 2021 Jul 5;11(1):13811. doi: 10.1038/s41598-021-93152-5.
2
The exploration of feature extraction and machine learning for predicting bone density from simple spine X-ray images in a Korean population.探索从韩国人群的简单脊柱 X 光图像中提取特征并使用机器学习预测骨密度的方法。
Skeletal Radiol. 2020 Apr;49(4):613-618. doi: 10.1007/s00256-019-03342-6. Epub 2019 Nov 23.
3
Application of machine learning algorithms to identify people with low bone density.机器学习算法在识别低骨密度人群中的应用。
Front Public Health. 2024 Apr 25;12:1347219. doi: 10.3389/fpubh.2024.1347219. eCollection 2024.
4
A Prediction Model for Osteoporosis Risk Using a Machine-Learning Approach and Its Validation in a Large Cohort.基于机器学习的骨质疏松风险预测模型及其在大样本队列中的验证。
J Korean Med Sci. 2023 May 29;38(21):e162. doi: 10.3346/jkms.2023.38.e162.
5
Can machine learning predict pharmacotherapy outcomes? An application study in osteoporosis.机器学习能预测药物治疗效果吗?一项在骨质疏松症中的应用研究。
Comput Methods Programs Biomed. 2022 Oct;225:107028. doi: 10.1016/j.cmpb.2022.107028. Epub 2022 Jul 21.
6
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
7
Machine Learning Can Improve Clinical Detection of Low BMD: The DXA-HIP Study.机器学习可提高低骨密度的临床检出率:DXA-HIP 研究。
J Clin Densitom. 2021 Oct-Dec;24(4):527-537. doi: 10.1016/j.jocd.2020.10.004. Epub 2020 Oct 20.
8
Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning.基于机器学习的绝经后妇女骨密度评估的骨质疏松风险预测。
Yonsei Med J. 2013 Nov;54(6):1321-30. doi: 10.3349/ymj.2013.54.6.1321.
9
Application of machine learning approaches for osteoporosis risk prediction in postmenopausal women.机器学习方法在绝经后妇女骨质疏松症风险预测中的应用。
Arch Osteoporos. 2020 Oct 23;15(1):169. doi: 10.1007/s11657-020-00802-8.
10
Developing and comparing deep learning and machine learning algorithms for osteoporosis risk prediction.开发并比较用于骨质疏松症风险预测的深度学习和机器学习算法。
Front Artif Intell. 2024 Jun 11;7:1355287. doi: 10.3389/frai.2024.1355287. eCollection 2024.

引用本文的文献

1
Deciphering the gut microbiome's metabolic code: pathways to bone health and novel therapeutic avenues.解读肠道微生物群的代谢密码:通往骨骼健康的途径和新的治疗方法。
Front Endocrinol (Lausanne). 2025 May 22;16:1553655. doi: 10.3389/fendo.2025.1553655. eCollection 2025.
2
Impact of Frailty and Other Factors as Estimated by HU to Predict Response to Anabolic Bone Medications.通过HU评估的衰弱及其他因素对预测合成代谢骨药物反应的影响。
J Clin Med. 2025 May 7;14(9):3247. doi: 10.3390/jcm14093247.
3
Association of novel inflammatory markers with osteoporosis index in older spine osteoporosis patients: NHANES 1999-2018 cross-sectional study.

本文引用的文献

1
PyMC: a modern, and comprehensive probabilistic programming framework in Python.PyMC:Python 中一个现代且全面的概率编程框架。
PeerJ Comput Sci. 2023 Sep 1;9:e1516. doi: 10.7717/peerj-cs.1516. eCollection 2023.
2
From Local Explanations to Global Understanding with Explainable AI for Trees.利用可解释人工智能实现从局部解释到树木的全局理解
Nat Mach Intell. 2020 Jan;2(1):56-67. doi: 10.1038/s42256-019-0138-9. Epub 2020 Jan 17.
3
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE .
老年脊柱骨质疏松症患者中新型炎症标志物与骨质疏松指数的关联:1999 - 2018年美国国家健康与营养检查调查横断面研究
Sci Rep. 2025 Mar 17;15(1):9128. doi: 10.1038/s41598-025-93378-7.
4
Development and reporting of artificial intelligence in osteoporosis management.人工智能在骨质疏松症管理中的发展和报告。
J Bone Miner Res. 2024 Oct 29;39(11):1553-1573. doi: 10.1093/jbmr/zjae131.
5
Machine learning application for prediction of surgical site infection after posterior cervical surgery.机器学习在预测颈椎后路手术后手术部位感染中的应用。
Int Wound J. 2024 Apr;21(4):e14607. doi: 10.1111/iwj.14607. Epub 2023 Dec 28.
6
An Integrative Study on the Inhibition of Bone Loss via Osteo-F Based on Network Pharmacology, Experimental Verification, and Clinical Trials in Postmenopausal Women.基于网络药理学、绝经后妇女的实验验证和临床试验的骨丢失抑制的整合研究:基于骨 F 的研究
Cells. 2023 Aug 3;12(15):1992. doi: 10.3390/cells12151992.
7
Machine learning prediction model for treatment responders in patients with primary biliary cholangitis.原发性胆汁性胆管炎患者治疗反应者的机器学习预测模型
JGH Open. 2023 Jun 1;7(6):431-438. doi: 10.1002/jgh3.12915. eCollection 2023 Jun.
8
Interpretable Deep-Learning Approaches for Osteoporosis Risk Screening and Individualized Feature Analysis Using Large Population-Based Data: Model Development and Performance Evaluation.基于大人群数据的骨质疏松风险筛查和个体化特征分析的可解释深度学习方法:模型开发和性能评估。
J Med Internet Res. 2023 Jan 13;25:e40179. doi: 10.2196/40179.
9
New Horizons: Artificial Intelligence Tools for Managing Osteoporosis.新视野:用于管理骨质疏松症的人工智能工具。
J Clin Endocrinol Metab. 2023 Mar 10;108(4):775-783. doi: 10.1210/clinem/dgac702.
10
Development and internal validation of a machine-learning-developed model for predicting 1-year mortality after fragility hip fracture.开发和内部验证一种机器学习开发的模型,用于预测脆性髋部骨折后 1 年的死亡率。
BMC Geriatr. 2022 May 24;22(1):451. doi: 10.1186/s12877-022-03152-x.
美国临床内分泌医师协会/美国内分泌学会 2020 年绝经后骨质疏松症诊断和治疗临床实践指南更新版
Endocr Pract. 2020 May;26(5):564-570. doi: 10.4158/GL-2020-0524.
4
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.绝经后妇女骨质疏松症的药物治疗:内分泌学会指南更新。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgaa048.
5
One-year mortality after hip fracture surgery and prognostic factors: a prospective cohort study.髋部骨折手术后 1 年的死亡率和预后因素:一项前瞻性队列研究。
Sci Rep. 2019 Dec 10;9(1):18718. doi: 10.1038/s41598-019-55196-6.
6
Management of glucocorticoid-induced osteoporosis: What is new?糖皮质激素性骨质疏松症的管理:有哪些新进展?
Int J Rheum Dis. 2019 Sep;22(9):1595-1597. doi: 10.1111/1756-185X.13680.
7
Personalising osteoporosis treatment for patients at high risk of fracture.为骨折高风险患者定制骨质疏松症治疗方案。
Lancet Diabetes Endocrinol. 2019 Oct;7(10):739-741. doi: 10.1016/S2213-8587(19)30266-9. Epub 2019 Aug 22.
8
Deep learning opens new horizons in personalized medicine.深度学习为个性化医疗开辟了新视野。
Biomed Rep. 2019 Apr;10(4):215-217. doi: 10.3892/br.2019.1199. Epub 2019 Mar 13.
9
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.绝经后妇女骨质疏松症的药物治疗:内分泌学会临床实践指南*。
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221.
10
Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis.泰国骨质疏松症基金会(TOPF)关于骨质疏松症管理的立场声明。
Osteoporos Sarcopenia. 2016 Dec;2(4):191-207. doi: 10.1016/j.afos.2016.10.002. Epub 2016 Dec 10.